Recombinant PD-1 anticorps
Aperçu rapide pour Recombinant PD-1 anticorps (ABIN7127671)
Antigène
Voir toutes PD-1 (PDCD1) AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human PD1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
-
Autre désignation
- PDCD1
-
Sujet
-
Background: Inhibitory cell surface receptor involved in the regulation of T-cell function during immunity and tolerance. Upon ligand binding, inhibits T-cell effector functions in an antigen-specific manner. Possible cell death inducer, in association with other factors.
Aliases: Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279), PDCD1, PD1
-
UniProt
- Q15116
-
Pathways
- Cancer Immune Checkpoints
Antigène
-